176
R. Baharfar et al. / Chinese Chemical Letters 21 (2010) 175–178
Scheme 1. .
triphenylphosphine, tert-butyl isocyanide were obtained from Fluka (Buchs, Switzerland) and were used without
further purification.
1.1. General procedure
To a magnetically stirred solution of 2,4-dihydroxy aceto (or benzo)phenone (2 mmol) and propiolic ester (2 mmol)
in 10 mL of toluene was added dropwise at À10 8C over 10 min triphenylphosphine (1 mmol, 0.262 g) or tert-butyl
isocyanide (1 mmol). The reaction mixture was then allowed to warm up to room temperature and stand for 24 h. The
solvent was removed under reduced pressure and the residue was separated by silica gel column chromatography
(Merck 230–400 mesh) using n-hexane: ethylacetate as eluent.
Methyl-(E)-3-(4-acetyl-3-hydroxyphenoxy)-2- acrylate (3a): Yellow powder, mp 91–95 8C, yield 70%; IR
(KBr)(ymax, cmÀ1): 1640 (C O), 1735 (C O), 3400–3500 (OH); 1H NMR (500 MHz, CDCl3): d 2.61 (s, 3 H, CH3),
3.76 (s, 3 H, OCH3), 5.73 (d, 1 H, 3JHH =12.1 Hz, CH), 6.61(dd, 1 H, 3JHH = 8.8, 4JHH = 2.4 Hz, CH), 6.64 (d, 1 H,
3JHH = 2.4 Hz, CH), 7.75 (d,1 H, 3JHH = 8.8 Hz, CH), 7.81 (d, 1 H, 3JHH = 12.1 Hz, OCH), 12.57 (s, 1 H, OH); 13
C
NMR (125 MHz, CDCl3): d 26.6 (CH3), 51.5 (OCH3), 104.3 (C CH), 105.7, 108.5 and 132.8 (CH), 116.8, 161.4,
164.4 (3C), 156.1 (OCH CH), 167.0 (C O, ester), 203.0 (C O, ketone); MS, (m/z, %): 236 (M+, 57), 221 (M+–Me,
100), 177 [M+–(COCH3, Me, H), 34], 43 (COCH3 , 48).
+
Ethyl-(E)-3-(4-acetyl-3-hydroxyphenoxy)-2- acrylate (3b): Yellow powder, mp 95–99 8C, yield 65%; IR
1
(KBr)(ymax, cmÀ1): 1625(C O), 1765 (C O), 3360–3480 (OH); H NMR (500 MHz, CDCl3): d 1.28 (t, 3 H,
3JHH = 7.1 Hz, CH3), 2.56 (s, 3 H, CH3), 4.20–4.28 (m, 2 H, OCH2), 5.89 (d, 1 H, 3JHH = 12.1 Hz, CH), 6.35(dd, 1 H,
4
3
3
3JHH = 8.8, JHH = 2.4 Hz, CH), 6.41 (d, 1 H, JHH = 2.4 Hz, CH), 7.64 (d, 1 H, JHH = 8.8 Hz, CH), 7.71 (d, 1 H,
3JHH = 12.1 Hz, OCH), 12.69 (s, 1 H, OH);13C NMR (125 MHz, CDCl3): d 14.0 (CH3), 26.2 (CH3), 61.6 (OCH2),
103.5 (C CH), 103.6, 107.7 and 133.1 (CH), 114.3, 162.7, 165.1 (3C), 156.2 (OCH CH), 165.9 (C O, ester), 202.7
(C O, ketone); MS, (m/z, %): 250 (M+, 60), 221 (M+–Et, 100), 177 [M+–(COCH3, Et, H), 34], 43 (COCH3 , 50).
+
Methyl-(E)-3-(4-benzoyl-3-hydroxyphenoxy)-2-acrylate (3c): Yellow powder, mp 91–93 8C, yield 80%; IR
(KBr)(ymax, cmÀ1): 1625 (C O), 1765 (C O), 3300–3500 (OH); 1H NMR (500 MHz, CDCl3): d 3.76 (s, 3 H, OCH3),
5.75 (d, 1 H, 3JHH = 12.1 Hz, CH), 6.58 (dd, 1 H, 3JHH = 8.8, 4JHH = 2.4 Hz, CH), 6.74 (d, 1 H, 3JHH = 2.4 Hz, CH),
7.50–7.64 (m, 5 H, CH), 7.65 (d, 1 H, 3JHH = 8.8 Hz, CH), 7.84 (d, 1 H, 3JHH = 12.1 Hz, OCH), 12.44 (s, 1 H, OH); 13
C
NMR (125 MHz, CDCl3): d 51.5 (OCH3), 104.5 (C CH), 105.8, 108.2, 128.5, 129.0, 132.0, 135.8 (CH), 156.0
(OCH CH), 116.1, 137.8, 161.4, 165.6 (4C), 167.0 (C O, ester), 200.4 (C O, ketone); MS, (m/z, %): 298 (M+, 100),
105 (Ph–C O+, 92), 239 (M+–CO2Me, 35), 77 (ph+, 45).
Ethyl-(E)-3-(4-benzoyl-3-hydroxyphenoxy)-2-acrylate (3d): Yellow powder, mp 95–97 8C, yield 85%; IR
1
(KBr)(ymax, cmÀ1): 1625 (C O), 1770 (C O), 3350–3500 (OH); H NMR (500 MHz, CDCl3): d 1.31 (t, 3 H,
3
3
3JHH = 7.1 Hz, CH3), 4.22 (q, 2 H, JHH = 7.1 Hz, OCH2), 5.74 (d, 1 H, JHH = 12.1 Hz, CH), 6.58 (dd, 1 H,
3JHH = 8.8, JHH = 2.4 Hz, CH), 6.74 (d, 1 H, JHH = 2.4 Hz, CH), 7.49–7.64 (m, 5 H, CH), 7.65 (d, 1 H,
3JHH = 8.8 Hz, CH), 7.82 (d, 1 H, 3JHH = 12.1 Hz, OCH), 12.44 (s, 1 H, OH); 13C NMR (125 MHz, CDCl3): d 14.3
(CH3), 60.4 (OCH2), 104.9 (C CH), 105.8, 108.2, 128.4, 129.0, 132.0, 135.8 (CH), 155.9 (OCH CH), 116.1, 137.8,
161.5, 165.6 (4C), 166.6 (C O, ester), 200.4 (C O, ketone); MS, (m/z, %): 312 (M+, 100), 105 (Ph–C O+, 96), 239
(M+–CO2Et, 40), 77 (ph+, 39).
4
3